VANCOUVER, British Columbia, Sept. 16, 2025 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (NASDAQ: INM) (“InMed” or the “Company”), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announced that Eric A. Adams, InMed’s CEO, will present live at the Life Sciences Virtual Investor Forum hosted by VirtualInvestorConferences.com, on September 18th, 2025.
InMed to Present at the Life Sciences Virtual Investor Forum September 18th, 2025
